AACR 2019

March 29–April 3, 2019 | Georgia World Congress Center, Atlanta, GA


Visualize a new path forward

Empowering the immune system to recognize and eliminate tumors has tremendous potential to change the way cancer is treated and eventually cured. At Fluidigm, we enable comprehensive cellular profiling of the immune system and the tumor microenvironment with proven mass cytometry and microfluidics technologies.

Whether you seek to target new biomarkers and pathways or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you gain new insights to reach your next research breakthrough.

Visit Fluidigm at Booth 1523

Exhibit Dates and Hours:
Sunday, March 31: 1:00–5:00 pm
Monday, April 1: 9:00 am–5:00 pm
Tuesday, April 2: 9:00 am–5:00 pm
Wednesday, April 3: 9:00 am–12:00 pm

Featured Products

Come visit our booth and learn how you can deeply profile tumors and the tumor immune response from every angle.

Hyperion™ Imaging System

Comprehensively interrogate complex cellular phenotypes and their interrelationships in the context of the tumor microenvironment with Imaging Mass Cytometry™.

Hyperion Imaging System


Deeply profile immune and tumor cell populations for phenotype and function, all in a single tube.

Helios, a CyTOF System

Biomark™ HD

Reveal the molecular signatures of tumor immune response using the Advanta™ IO Gene Expression Assay on the Biomark HD.

Biomark HD


Achieve significant cost savings and reduced hands-on time with automated NGS library prep.


For more information, visit the AACR 2019 event website.

For Research Use Only. Not for use in diagnostic procedures.